Controlling cellular packing and hypoxia in 3D tumor spheroids via DNA interactions
Source abstract
Abstract
Tumor spheroids represent valuable in vitro models for studying cancer biology and evaluating therapeutic strategies. In this study, we investigated the impact of varying lengths of DNA-modified cell surfaces on spheroid formation, cellular adhesion molecule expression, and hypoxia levels within 4T1 mouse breast cancer spheroids. Through a series of experiments, we demonstrated that modifying cell surfaces with biotinylated DNA strands of different lengths facilitated spheroid formation without significantly altering the expression of fibronectin and e-cadherin, key cellular adhesion molecules. However, our findings revealed a notable influence of DNA length on hypoxia levels within the spheroids. As DNA length increased, hypoxia levels decreased, indicating enhanced intercellular spacing and porosity within the spheroid structure. These results contribute to a better understanding of how DNA modification of cell surfaces can modulate spheroid architecture and microenvironmental conditions. Such insights may have implications for developing therapeutic interventions targeting the tumor microenvironment to improve cancer treatment efficacy.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Cancer Genomics and Diagnostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical and Biological Engineering, University of Colorado, Boulder, 596 UCB, Boulder, CO, 80303, USA
Materials Science and Engineering Program, University of Colorado, Boulder, 596 UCB, Boulder, CO, 80303, USA
Biomedical Engineering Program, University of Colorado, Boulder, 596 UCB, Boulder, CO, 80303, USA
Funding
National Science Foundation · National Institutes of Health
References (42)
Show source-provided references
1. de Visser · Cancer Cell · 2023 · 41 · 37410.1016/j.ccell.2023.02.016 ↗
2. Anderson · Curr. Biol. · 2020 · 30 · R92110.1016/j.cub.2020.06.081 ↗
3. Molina · Acta Biomater. · 2019 · 100 · 3810.1016/j.actbio.2019.09.029 ↗
4. van de Wetering · Cell · 2015 · 161 · 93310.1016/j.cell.2015.03.053 ↗
5. Sachs · Cell · 2018 · 172 · 37310.1016/j.cell.2017.11.010 ↗
6. S. M.Kirsh , S. A.Pascetta and J.Uniacke , in The Tumor Microenvironment: Methods and Protocols , ed. J. Ursini-Siegel , Springer US , New York, NY , 2023 , pp. 273–28510.1007/978-1-0716-2914-7_17 ↗
7. Perche · Cancer Biol. Ther. · 2012 · 13 · 120510.4161/cbt.21353 ↗
8. Mittler · Front. Oncol. · 2017 · 710.3389/fonc.2017.00293 ↗
9. Agrawal · Mater. Today Bio · 2023 · 23 · 10082110.1016/j.mtbio.2023.100821 ↗
10. Chandrasekaran · Integr. Biol. · 2015 · 7 · 32410.1039/c4ib00298a ↗
11. Kuo · Biomaterials · 2014 · 35 · 156210.1016/j.biomaterials.2013.11.008 ↗
12. Rovere · Front. Bioeng. Biotechnol. · 2023 · 1110.3389/fbioe.2023.1297644 ↗
13. Hwang · J. Exp. Clin. Cancer Res. · 2019 · 38 · 25810.1186/s13046-019-1225-9 ↗
14. Saemundsson · ACS Biomater. Sci. Eng. · 2023 · 9 · 318510.1021/acsbiomaterials.3c00546 ↗
15. Liao · Semin. Cancer Biol. · 2023 · 88 · 17210.1016/j.semcancer.2022.12.011 ↗
16. Ortmann · BMJ Oncol. · 2024 · 310.1136/bmjonc-2023-000154 ↗
17. Akakura · Cancer Res. · 2001 · 61 · 6548
18. Brand · FASEB J. · 1997 · 11 · 38810.1096/fasebj.11.5.9141507 ↗
19. Seagroves · Mol. Cell. Biol. · 2001 · 21 · 343610.1128/MCB.21.10.3436-3444.2001 ↗
20. Jiang · Cancer Res. · 1997 · 57 · 5328
21. Chen · Am. J. Pathol. · 2003 · 162 · 128310.1016/S0002-9440(10)63924-7 ↗
22. Zagzag · J. Cell. Physiol. · 2003 · 196 · 39410.1002/jcp.10306 ↗
23. Bernards · Nature · 2002 · 418 · 82310.1038/418823a ↗
24. Koontongkaew · J. Cancer · 2013 · 4 · 6610.7150/jca.5112 ↗
25. Doedens · Cancer Res. · 2010 · 70 · 746510.1158/0008-5472.CAN-10-1439 ↗
26. Laoui · Cancer Res. · 2014 · 74 · 2410.1158/0008-5472.CAN-13-1196 ↗
27. Friedrich · Nat. Protoc. · 2009 · 4 · 30910.1038/nprot.2008.226 ↗
28. Vakhshiteh · J. Nanobiotechnol. · 2023 · 21 · 24910.1186/s12951-023-02021-y ↗
29. Brüningk · Sci. Rep. · 2020 · 10 · 165310.1038/s41598-020-58569-4 ↗
30. Ganguly · Biomater. Sci. · 2021 · 9 · 791110.1039/D1BM01193F ↗
31. Mirkin · Nature · 1996 · 382 · 60710.1038/382607a0 ↗
32. Aldaye · Science · 2008 · 321 · 179510.1126/science.1154533 ↗
33. Mao · Nature · 1999 · 397 · 14410.1038/16437 ↗
34. Li · ACS Nano · 2011 · 5 · 878310.1021/nn202774x ↗
35. Zhang · J. Am. Chem. Soc. · 1994 · 116 · 166110.1021/ja00084a006 ↗
36. Douglas · Science · 2012 · 335 · 83110.1126/science.1214081 ↗
37. Yoo · BMC Cancer Imaging · 2020 · 20 · 8510.1186/s40644-020-00362-7 ↗
38. Rothemund · Nature · 2006 · 440 · 29710.1038/nature04586 ↗
39. Ståhl · Trends Biotechnol. · 2017 · 35 · 69110.1016/j.tibtech.2017.04.007 ↗
40. Perez · Handb. Exp. Pharmacol. · 2004 · 310.1007/978-3-540-68170-0_1 ↗
41. R. P. D.Bank
42. Kuzuya · Nucleic Acids Symp. Ser. · 2008 · 52 · 68110.1093/nass/nrn344 ↗